WINDLAS.NSE Windlas Biotech Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Windlas Biotech Ltd. market cap is 10.98B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Windlas Biotech Ltd. 52 week high is 590.85 as of May 07, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Windlas Biotech Ltd. 52 week low is 260.10 as of May 07, 2024.

Windlas Biotech Ltd. stock price today is 519.05.

Windlas Biotech Ltd. stock price yesterday was 530.15.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Windlas Biotech Ltd.’s P/E ratio is 20.98.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Windlas Biotech Ltd. P/B ratio is 2.6383.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Windlas Biotech Ltd.'s EBITDA is 7.97.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Windlas Biotech Ltd. 50-day moving average is 538.38.

Windlas Biotech Ltd. has 1,049 employees.